A novel anticancer effect of butein: Inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells

Research output: Contribution to journalArticlepeer-review

93 Scopus citations

Abstract

There is increasing evidence that epithelial-mesenchymal transition (EMT) plays a critical role in cancer metastasis. Butein is a polyphenolic compound, which has been found to exhibit anti-proliferation effects on cancer cells. Here, we report that in addition to its function as an anti-proliferation agent, butein can inhibit migration and invasion through the ERK1/2 and NF-κB signaling pathways in human bladder cancer cells, and this inhibitory effect may be associated with reversal of EMT. These results were further confirmed by RNAi-mediated suppression of NF-κB, which partly reverses EMT and inhibits cell invasive ability in vitro. These results suggest a novel function of butein as an invasion inhibitor in bladder cancer.

Original languageEnglish
Pages (from-to)1821-1828
Number of pages8
JournalFEBS Letters
Volume582
Issue number13
DOIs
StatePublished - 11 Jun 2008
Externally publishedYes

Keywords

  • Bladder cancer
  • Butein
  • Epithelial-mesenchymal transition (EMT)
  • Invasion
  • NF-κB

Fingerprint

Dive into the research topics of 'A novel anticancer effect of butein: Inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells'. Together they form a unique fingerprint.

Cite this